| Combined effects of buffer and adrenergic agents on postresuscitation myocardial function. | |
| | |
MedLine Citation:
|
PMID: 10525099 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Although buffer agents alone have failed to improve the success of resuscitation, we now examine the widely held concept that it is the combined effect of alkaline buffer and adrenergic agents that improves outcomes of cardiopulmonary resuscitation. In the present report, the effects of both CO(2)-consuming and CO(2)-generating buffer agents in combination with adrenergic vasopressor drugs were investigated. Ventricular fibrillation was electrically induced in Sprague-Dawley rats weighing between 450 and 550 g. Precordial compression and mechanical ventilation were initiated after 8 min of untreated ventricular fibrillation. Animals were then randomized to receive bolus injections of either inorganic sodium bicarbonate buffer, organic tromethamine buffer, or saline placebo. The beta(1) adrenergic effects of epinephrine were blocked with esmolol. The vasopressor amine was injected 2 min after injection of the buffer agent. Electrical defibrillation was attempted at the end of 8 min of precordial compression. In 15 additional animals, the sequence of administration of the adrenergic vasopressor and buffer agents was reversed such that the adrenergic vasopressor was injected before the buffer agents. All animals were restored to spontaneous circulation. Both bicarbonate and tromethamine significantly decreased coronary perfusion pressure from 26 to 15 mm Hg and reduced the magnitude of the vasopressor effect of the adrenergic vasopressor. When the vasopressor preceded the buffer, declines in coronary perfusion pressure after administration of buffer agents were prevented. In each instance, however, greater impairment of postresuscitation myocardial function and decreased postresuscitation survival were observed after treatment with buffer agents. |
| | |
Authors:
|
S Sun; M H Weil; W Tang; H P Povoas; E Mason |
Related Documents
:
|
7609749 - Blunt impact to the chest leading to sudden death from cardiac arrest during sports act... 8534689 - Peritoneal transport evaluation in peritonitis: comparison between methods. 11090799 - Factors associated with preventable out-of-hospital nontraumatic cardiac arrest. 9114789 - Evaluation of cardiac rhythm disturbances during extravehicular activity. 19491689 - Complete recovery from aneurysmal subarachnoid hemorrhage associated with out-of-hospit... 8227809 - Active compression-decompression resuscitation: analysis of transmitral flow and left v... 10969679 - Surgical treatment of acquired left ventricular pseudoaneurysms. 1132119 - Evaluation of precordial electrocardiographic mapping as a means of assessing changes i... 8800429 - Comparison of myoglobin, creatine kinase-mb, and cardiac troponin i for diagnosis of ac... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: The Journal of pharmacology and experimental therapeutics Volume: 291 ISSN: 0022-3565 ISO Abbreviation: J. Pharmacol. Exp. Ther. Publication Date: 1999 Nov |
Date Detail:
|
Created Date: 1999-11-24 Completed Date: 1999-11-24 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0376362 Medline TA: J Pharmacol Exp Ther Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 773-7 Citation Subset: IM |
Affiliation:
|
The Institute of Critical Care Medicine, Palm Springs, California 92262-5309, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Agonists
/
pharmacology Animals Blood Pressure / drug effects Buffers* Coronary Vessels / drug effects Drug Interactions Electric Countershock Epinephrine / pharmacology Heart / drug effects Hemodynamics / drug effects* Male Propanolamines / pharmacology Random Allocation Rats Rats, Sprague-Dawley Resuscitation / adverse effects*, mortality Sodium Bicarbonate / therapeutic use* Time Factors Tromethamine / therapeutic use* Vascular Resistance / drug effects |
| Grant Support | |
ID/Acronym/Agency:
|
R01 HL54322/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Agonists; 0/Buffers; 0/Propanolamines; 144-55-8/Sodium Bicarbonate; 51-43-4/Epinephrine; 77-86-1/Tromethamine; 84057-94-3/esmolol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A transgenic model of acetaldehyde overproduction accelerates alcohol cardiomyopathy.
Next Document: Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and t...